Avanos Medical, Inc. · NYSE (us_market)
Healthcare · Medical Devices · United States
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-02-20$15.46 RISE2026-03-20$13.05 PEAK2026-05-11$24.81 80d | -15.6% 28d | Missed | Missed | — | — | +90.1% 52d | Missed |
DROP2025-09-05$12.72 RISE2025-11-05$10.66 PEAK2026-02-02$13.47 150d | -16.2% 61d | Missed | Missed | — | — | +26.4% 89d | Missed |
DROP2025-04-02$14.52 RISE2025-08-05$9.89 PEAK2025-09-05$12.72 156d | -31.9% 125d | Missed | Missed | — | — | +28.6% 31d | Missed |
DROP2023-12-21$22.99 RISE2024-04-25$17.85 PEAK2024-07-23$22.70 215d | -22.4% 126d | Missed | Missed | — | — | +27.2% 89d | Missed |
DROP2023-07-20$26.31 RISE2023-10-26$17.64 PEAK2023-12-21$22.99 154d | -33.0% 98d | Missed | Missed | — | — | +30.3% 56d | Missed |
DROP2023-02-02$31.75 RISE2023-05-19$22.53 PEAK2023-07-20$26.31 168d | -29.0% 106d | Missed | Missed | — | — | +16.8% 62d | Missed |
DROP2022-08-15$29.59 RISE2022-10-12$19.88 PEAK2022-12-29$27.37 136d | -32.8% 58d | Missed | Missed | — | — | +37.7% 78d | Missed |
DROP2022-02-25$35.40 RISE2022-06-16$24.87 PEAK2022-08-15$29.59 171d | -29.7% 111d | Missed | Missed | — | — | +19.0% 60d | Missed |
DROP2021-11-03$36.02 RISE2022-02-18$28.87 PEAK2022-02-25$35.40 114d | -19.9% 107d | Missed | Missed | — | — | +22.6% 7d | Missed |
DROP2021-11-03$36.02 RISE2021-12-13$29.25 PEAK2022-01-04$35.77 62d | -18.8% 40d | Missed | Missed | — | — | +22.3% 22d | Missed |
DROP2021-06-17$40.45 RISE2021-10-05$31.18 PEAK2021-11-03$36.02 139d | -22.9% 110d | Missed | Missed | — | — | +15.5% 29d | Missed |
DROP2020-02-25$34.41 RISE2020-06-26$27.33 PEAK2020-09-16$33.94 204d | -20.6% 122d | Missed | Missed | — | — | +24.2% 82d | Missed |
DROP2020-02-25$34.41 RISE2020-05-13$25.78 PEAK2020-06-08$33.86 104d | -25.1% 78d | Missed | Missed | — | — | +31.3% 26d | Missed |
DROP2020-02-25$34.41 RISE2020-03-23$20.64 PEAK2020-06-08$33.86 104d | -40.0% 27d | Missed | Missed | — | — | +64.1% 77d | Missed |
DROP2020-01-07$34.20 RISE2020-02-03$27.50 PEAK2020-02-25$34.41 49d | -19.6% 27d | Missed | Missed | — | — | +25.1% 22d | Missed |
Health care stocks flashing warning for momentum investors. RSI measures stock strength, overbought when above 70. AVNS +127% past 6 months, AGL +212% past month.
AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.
AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Avanos Medical tops Q1 revenue estimates on strong SNS growth, but margin pressure and PM&R weakness weigh on earnings and profitability.
Avanos Medical tops Q1 revenue estimates on strong SNS growth, but margin pressure and PM&R weakness weigh on earnings and profitability.
Avanos Medical (AVNS) delivered earnings and revenue surprises of -4.35% and +7.61%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical (AVNS) delivered earnings and revenue surprises of -4.35% and +7.61%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was USD 182.2 million compared to USD 167.5 million a year...
Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2026 financial results.
Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.14 by 57.14 percent. This is a 15.38 percent decrease over earnings of $0.26 per share from the
ALPHARETTA, Ga. — ALPHARETTA, Ga. — Avanos Medical, Inc. on Tuesday reported first-quarter earnings of $5.1 million. On a per-share basis, the Alpharetta, Georgia-based company said it had...
InspireMD (NSPR) delivered earnings and revenue surprises of +15.79% and +25.85%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
InspireMD (NSPR) delivered earnings and revenue surprises of +15.79% and +25.85%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Stocks AVNS, APLS, and CERS in healthcare sector flashing warning to momentum-sensitive investors. High RSI values & price action indicate overbought conditions. AVNS at 90. APLS at 86. CERS at 86. Avanos Medical, Apellis Pharmaceuticals, and Cerus Corp have seen significant gains and have 52-week highs.
Wall Street Week Ahead: key earnings (Apple, Microsoft), Fed decision, GDP & jobs, IPOs and dividends. Read here for more details.
By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it started two new U.S. collaborations to position its digital tomosynthesis system Nanox.ARC across the country. The first partnership is with Howard Technology Solutions to utilize 300 Nanox.ARC over a period of three years, and the second will deploy the system in clinics and hospitals with […]
By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it started two new U.S. collaborations to position its digital tomosynthesis system Nanox.ARC across the country. The first partnership is with Howard Technology Solutions to utilize 300 Nanox.ARC over a period of three years, and the second will deploy the system in clinics and hospitals with […]
by Dave Pacitti, Chief Executive Officer - Avanos Medical In March, I joined leaders from across the MedTech industry at the AdvaMed CEO Summit. These moments to step back are valuable, not just for...
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| AVNS | +0.57% | +77.40% | +120.84% | +97.30% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | -2.40% | +83.11% | +124.28% | +84.61% |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-10upcoming | 0.16 | — | — |
| 2026-05-05 | 0.14 | 0.22 | +57.14% |
| 2026-02-24 | 0.25 | 0.29 | +16.00% |
| 2025-11-05 | 0.12 | 0.22 | +83.33% |
| 2025-08-05 | 0.15 | 0.17 | +13.33% |
| 2025-05-06 | 0.18 | 0.26 | +44.44% |
| 2025-02-26 | 0.40 | 0.43 | +8.40% |
| 2024-10-30 | 0.35 | 0.36 | +1.89% |
| 2024-07-31 | 0.29 | 0.34 | +18.60% |
| 2024-05-02 | 0.21 | 0.19 | -10.94% |
| 2024-02-20 | 0.37 | 0.32 | -12.73% |
| 2023-11-01 | 0.28 | 0.30 | +7.14% |
| 2023-08-09 | 0.32 | 0.24 | -25.77% |
| 2023-05-03 | 0.28 | 0.27 | -1.82% |
| 2023-02-21 | 0.49 | 0.60 | +22.45% |
| 2022-11-02 | 0.35 | 0.38 | +7.80% |